Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Unichem Laboratories gets USFDA’s approval for Piroxicam Capsules

Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and Rheumatoid Arthritis (RA). For the relief of rheumatoid arthritis and osteoarthritis, the dosage is 20 mg given orally once daily. If desired, the daily dose may be divided. Usually lowest effective dosage for the shortest duration, consistent with individual patient treatment goals is recommended.

The product will be commercialized from Unichem’s Goa plant. Active Pharmaceutical Ingredient (API) will also be made in house at Roha API Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives.



This post first appeared on Udaipur Kiran, please read the originial post: here

Share the post

Unichem Laboratories gets USFDA’s approval for Piroxicam Capsules

×

Subscribe to Udaipur Kiran

Get updates delivered right to your inbox!

Thank you for your subscription

×